20051113
 Technology & Health Brief -- Biota Ltd.: Company Says French Order For Flu Drug Boosts Glaxo Suit   The Wall Street Journal,  Nov 14, 2005  Australia's Biota Ltd., the biotechnology company known for developing the antiflu drug Relenza, said Friday that a huge order for the product from the French government will add potency to its protracted lawsuit against GlaxoSmithKline PLC.   
